Application | Comment | Organism |
---|---|---|
drug development | glycerol kinase 5 (GK5) is a potential therapeutic target for treatment of NSCLC with resistance to EGFR tyrosine kinase inhibitors | Homo sapiens |
Cloned (Comment) | Organism |
---|---|
transfection of the enzyme in to adenocarcinma cell lines PC-9 and H1975 using a lentiviral vector (Lv105), quantitative RT-PCR enzyme expression analysis | Homo sapiens |
Protein Variants | Comment | Organism |
---|---|---|
additional information | silencing using short hairpin RNA (shRNA) vectors against the GK5 genes shGK5-1 and shGK5-2. shGK5-1 and -2 significantly inhibit GK5 expressions. Morphological examination shows that GK5 knockdown reduces the number of PC9R cells transfected with shGK5 compared to those transfected with negative control shRNA for 24 h and then treated with 0.001 mM gefitinib for 72 h. The CCK8 assays reveals that transfection of PC9R cells with either shGK5-1 or -2 enhances gefitinib-induced apoptosis. GK5 knockdown induces PC9R cell apoptosis and cell cycle arrest in the presence of gefitinib | Homo sapiens |
Metals/Ions | Comment | Organism | Structure |
---|---|---|---|
Mg2+ | required | Homo sapiens |
Natural Substrates | Organism | Comment (Nat. Sub.) | Natural Products | Comment (Nat. Pro.) | Rev. | Reac. |
---|---|---|---|---|---|---|
ATP + glycerol | Homo sapiens | - |
ADP + sn-glycerol 3-phosphate | - |
? |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Homo sapiens | Q6ZS86 | - |
- |
Source Tissue | Comment | Organism | Textmining |
---|---|---|---|
lung | - |
Homo sapiens | - |
lung adenocarcinoma cell | - |
Homo sapiens | - |
NCI-H1975 cell | - |
Homo sapiens | - |
non-small cell lung cancer cell | - |
Homo sapiens | - |
PC-9 cell | - |
Homo sapiens | - |
Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|
ATP + glycerol | - |
Homo sapiens | ADP + sn-glycerol 3-phosphate | - |
? |
Synonyms | Comment | Organism |
---|---|---|
GK5 | - |
Homo sapiens |
glycerol kinase 5 | - |
Homo sapiens |
Organism | Comment | Expression |
---|---|---|
Homo sapiens | the mRNA and protein levels of GK5 are significantly upregulated in gefitinib-resistant human lung adenocarcinoma PC9R and H1975 cells compared with gefitinib-sensitive PC9 cells | up |
General Information | Comment | Organism |
---|---|---|
malfunction | silencing GK5 in PC9R cells induces mitochondrial damage, caspase activation, cell cycle arrest, and apoptosis via SREBP1/SCD1 signaling pathway. The exosomal mRNA of GK5 in the plasma of patients with gefitinib-resistant adenocarcinoma is significantly higher compared with that of gefitinib-sensitive patients. GK5 knockdown induces PC9R cell apoptosis and cell cycle arrest in the presence of gefitinib, as well as PC9R cell mitochondrial dysfunction and caspase activation. GK5 knockdown suppresses tumor proliferation in vivo | Homo sapiens |
physiological function | GK5 confers gefitinib resistance in lung cancer by inhibiting apoptosis and cell cycle arrest. Role of glycerol kinase 5 (GK5) in mediating gefitinib resistance in non-small cell lung cancer (NSCLC), overview. GK5 confers gefitinib resistance through upregulating SCD1 expression, molecular mechanism underlying GK5-mediated gefitinib resistance | Homo sapiens |